COVID-19 RWD Waterfall Strategy

How real-world data (RWD) from open and closed claims and beyond can be layered to better explore the variant-driven surge in COVID-19 

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gilead Sciences

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of ...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

The role of RWE: Longitudinal patient insights bridging clinical and real-world data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...

2021 Data Imperatives: The pulse of the industry

The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-1...

HVPCI reports positive swing to patient confidence as the year comes to a close

December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confidence...

HVPCI notes a 5-point dip as COVID-19 restrictions tighten and telehealth fatigue sets in

November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confide...

The modern way to data: Design, build and implement your data strategy

Building a modern data infrastructure within today’s healthcare enterprise is challenging on many levels. Your organizat...

HVPCI reports “98” and marks six-month milestone of patient monitoring amid COVID-19 pandemic

October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confiden...

Subscribe to the HealthVerity blog

Contact us